Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Dunbia, Northern Ireland | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Red meat is an integral component of the habitual diet among the UK and Irish population, with adults consuming an average of 71grams/day. Although typically high in saturated fatty acids (SFA), red meat is also an important dietary source of protein and essential nutrients including iron, zinc, B vitamins and long chain n-3 polyunsaturated fatty acids (PUFA) which provide numerous benefits to human health, particularly related to cardiovascular disease (CVD) risk. N-3 and n-6 PUFA are a family of fatty acids with important roles in cardiovascular health, and it is often recommended in dietary guidelines to replace SFA with unsaturated fats, such as PUFA. Owing to the social and economic burden of CVD, increasing the proportions of these unsaturated fatty acids, in combination with a reduction in SFA within meat, could have a large impact on CVD risk at the population level, whilst retaining the beneficial nutrients and n-3 PUFA which meat provides.
In this research, a total of 90 eligible and consenting participants will be randomly allocated to consume three portions per week of n-3 enriched beef (from either dietary supplemented or grass-fed cattle) or control beef (from standard supply). This beef will be offered within a lunchtime meal and served from the Human Intervention Studies Unit at Ulster University, Coleraine for a period of 5 weeks. A fasting blood sample will be taken before and after intervention to determine the effect the n-3 enriched beef on cholesterol concentrations, lipid profile, PUFA status and inflammation. Blood pressure, stiffness of the arteries and body shape, size and composition will also be assessed, and some health and lifestyle habits will be captured using questionnaires.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Beef from standard supply | Placebo Comparator |
| |
| n-3 enriched beef from dietary supplement finished cattle | Experimental |
| |
| n-3 enriched beef from grass finished cattle | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Three portions per week (690g beef (raw weight)) for 5 weeks | Dietary Supplement | Lunches served in Human Intervention Studies Unit |
|
| Measure | Description | Time Frame |
|---|---|---|
| Cholesterol levels | Plasma cholesterol measured colormetrically | Change at 5 weeks from baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Lipid profile | Plasma lipids measured colormetrically | Change at 5 weeks from baseline |
| Polyunsaturated fatty acid profile | Serum fatty acids measured by GC-MS |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Human Intervention Studies Unit, Ulster University | Coleraine | Co.Londonderry | BT52 1SA | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008659 | Metabolic Diseases |
| D007249 | Inflammation |
| ID | Term |
|---|---|
| D009750 | Nutritional and Metabolic Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069466 | Red Meat |
| D000074584 | WW Domain-Containing Oxidoreductase |
| ID | Term |
|---|---|
| D008460 | Meat |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
Not provided
Not provided
Double blind randomised controlled trial
Not provided
Not provided
Double blind
| Change at 5 weeks from baseline |
| Pulse Wave Velocity | Measured by Sphygmocor XCEL | Change at 5 weeks from baseline |
| Blood pressure | Measured by electronic blood pressure monitor | Change at 5 weeks from baseline |
| Whole body composition | Measured by Dual Energy X-ray Absorptiometry | Change at 5 weeks from baseline |
| Inflammation status | Measured by ELISA | Change at 5 weeks from baseline |
| D019602 |
| Food and Beverages |
| D000074583 | Short Chain Dehydrogenase-Reductases |
| D064430 | NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases |
| D000429 | Alcohol Oxidoreductases |
| D010088 | Oxidoreductases |
| D004798 | Enzymes |
| D045762 | Enzymes and Coenzymes |
| D025521 | Tumor Suppressor Proteins |
| D009363 | Neoplasm Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |